Home » Blepharospasm
Blepharospasm is a neurological condition that causes involuntary closing, twitching, or blinking of the eyelids. It can affect one or both eyes and interfere with vision and daily activities.
Blepharospasm is a type of focal dystonia, which means abnormal muscle contractions in one part of the body. It is estimated to affect about 16 to 133 people per million. Women and older adults are more commonly affected.
Botulinum toxin injections are approved by the Therapeutic Goods Administration (TGA) for treating blepharospasm in patients who have had an inadequate response to other treatments. The injections need to be repeated every few months to maintain the effect.
Mild twitching of the eyelids is typically called tics or twitches. In blepharospasm, the abnormal twitching or closing of the eyelids is much more severe, causing discomfort, visual impairment, and social embarrassment.
Some of the symptoms of blepharospasm are:
The symptoms may vary in severity and frequency, and they may get worse over time. They may also be triggered by stress, fatigue, anxiety, bright lights, wind, or air pollution.
DBS is used to treat various neurological and psychiatric conditions, including:
Although not without risks, DBS is safe and highly effective in properly selected patients. It is typically recommended for individuals whose neurological conditions have not responded well to medications or who cannot tolerate high doses due to side effects.
Treatment with DBS results in improved functioning and a reduced need for medications in some cases.
Unlike ablative surgery, DBS does not remove or destroy brain tissue. This can lead to a faster recovery time and reduced risk of complications.
Although DBS works by providing continuous stimulation, it can also be adjusted through remote control, allowing patients to turn it on and off as needed.
DBS has been shown to produce long-lasting results in reducing the symptoms of various disorders. A recent study revealed that DBS remains effective after 15 years in patients with Parkinson’s disease.
If a patient experiences adverse effects, the DBS program can be adjusted to avoid them. If the treatment is no longer needed, the electrodes and pulse generator can be removed without causing permanent damage.
Like any surgical procedure, there are potential risks associated with deep brain stimulation. However, most are mild and temporary. More serious complications, such as infection or stroke, may occur in rare cases. These can be prevented by proper pre-procedure screening and careful monitoring during the recovery period.
Risks and side effects of DBS placement
Additionally, patients should monitor battery life closely since IPGs traditionally require replacement every three years due to their limited capacity.
Botulinum toxin injections can reduce the frequency and severity of eyelid spasms in most people with blepharospasm.
Patients can expect to see improvements in their symptoms within 2-4 days post-injection, with peak effects usually occurring after a week. The results typically last up to 4 months, after which the injection may need to be repeated.
Botulinum toxin injections are generally well-tolerated and have few side effects. These can include dry eyes, drooping eyelids, blurred vision, and increased sensitivity to light. However, these side effects are usually temporary and resolve on their own.
At Melbourne NeuroCare, we have a team of experts who can provide you with botulinum toxin injections and other advanced treatments for various movement disorders. To book an appointment or learn more about our clinic, please call us at 1300 080 784. We look forward to hearing from you soon!
©2024 Melbourne NeuroCare | Web design by Quikclicks